Contract №6443407 Pharmaceutical products. Winner: Fresenius Kabi Polska Sp. z o.o.

Link to original

To view links to the source need to register

Publication date

16-02-2018

Description

Section I
1. Name and addresses
  Katowickie Centrum Onkologii
  ul. Raciborska 26
  Katowice
  40-074
  Poland
  Telephone: +48 324200210
  E-mail: [email protected]
  Fax: +48 322514533
2. Type of the contracting authority:
  Body governed by public law
3. Main activity:
  Health
Section II
1. Scope of the procurement:
  1. Title:
    
    Zakup i dostarczanie leków 266 Pakietów
    
    Reference number: KCO/PN/41/2017
  2. Main CPV code:
    33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33141110, 33141110
  3. Type of contract:
    Supplies
  4. Short description:
    
    Przedmiotem zamówienia jest zakup i dostarczanie produktów leczniczych – leków, preparatów do żywienia i materiałów opatrunkowych dla potrzeb Katowickiego Centrum Onkologii w postaciach, dawkach i szacunkowych ilościach, których wykaz w podziale na Pakiety od Nr 1 do Nr 266 stanowi Załącznik Nr 2 do SIWZ – Oferta Cenowa. Przedmiotem zamówienia jest produkt leczniczy – lek o nazwie międzynarodowej w określonej przez Zamawiającego postaci i dawce, natomiast umieszczona nazwa handlowa jest jedynie egzemplifikacją, podaną celem usystematyzowania katalogu.
    
    Oznaczenie przedmiotu zamówienia we Wspólnym Słowniku Zamówień:
    
    33600000-6 produkty farmaceutyczne
    
    33141110-4 opatrunki
    
    Wymagania:
    
    1. Ilości zamawianego produktu leczniczego mogą ulec zmniejszeniu, w czasie obowiązywania umowy
    
    W zależności od bieżących potrzeb Zamawiającego związanych z udzielanymi świadczeniami zdrowotnymi i będą wynikały z bieżących zamówień bez możliwości dochodzenia roszczeń przez Wykonawcę z tytułu zmniejszenia.
  5. Information about lots:
    This contract is divided into lots: yes
  6. Total value of the procurement:
    Value excluding VAT: 33 434 882.04 PLN
2. Description
  1. Title:
    
    PAKIET 1
  2. Additional CPV code(s):
    33600000
  3. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  4. Description of the procurement:
    
    Abirateron Zytiga 250 mg x 120 tabl. 300.
  5. Award criteria:
  6. Information about options:
    Options: no
  7. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  8. Additional information:
  9. Title:
    
    PAKIET 2
  10. Additional CPV code(s):
    33600000
  11. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  12. Description of the procurement:
    
    Axitynib Inlyta tabl. powl. 1 mg x 56 szt. 300.
    
    Axitynib Inlyta tabl. powl. 5 mg x 56 szt. 200.
  13. Award criteria:
  14. Information about options:
    Options: no
  15. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  16. Additional information:
  17. Title:
    
    PAKIET 3
  18. Additional CPV code(s):
    33600000
  19. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  20. Description of the procurement:
    
    Bleomycinum Bleomedac 15 j x 1 fiol. 400.
  21. Award criteria:
  22. Information about options:
    Options: no
  23. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  24. Additional information:
  25. Title:
    
    PAKIET 4
  26. Additional CPV code(s):
    33600000
  27. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  28. Description of the procurement:
    
    Capecitabine Capecitabine, 500 mg, tabl.powl., 120 tabl. 600.
    
    Capecitabine Capecitabine, 300 mg, tabl.powl., 60 tabl. 150.
    
    Capecitabine Capecitabine, 150 mg, tabl.powl., 60 tabl. 100.
  29. Award criteria:
  30. Information about options:
    Options: no
  31. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  32. Additional information:
  33. Title:
    
    PAKIET 5
  34. Additional CPV code(s):
    33600000
  35. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  36. Description of the procurement:
    
    Carboplatinum Carboplatin 50 mg, inj., 1 fiol. 50.
    
    Carboplatinum Carboplatin 150 mg, inj., 1 fiol. 50.
    
    Carboplatinum Carboplatin 450 mg, inj., 1 fiol. 50.
    
    Carboplatinum Carboplatin 600 mg, inj., 1 fiol. 1500.
  37. Award criteria:
  38. Information about options:
    Options: no
  39. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  40. Additional information:
  41. Title:
    
    PAKIET 6
  42. Additional CPV code(s):
    33600000
  43. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  44. Description of the procurement:
    
    Cetuximabum Erbitux 100mg, r-r do inf., 1 fiol. a 20 ml 1800.
    
    Cetuximabum Erbitux 500mg, r-r do inf., 1 fiol. a 100 ml 30.
  45. Award criteria:
  46. Information about options:
    Options: no
  47. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  48. Additional information:
  49. Title:
    
    PAKIET 7
  50. Additional CPV code(s):
    33600000
  51. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  52. Description of the procurement:
    
    Crizotynibum Xalkori kaps.twarde 200 mg, 60 szt. 50.
    
    Crizotynibum Xalkori kaps.twarde 250 mg, 60 szt. 70.
  53. Award criteria:
  54. Information about options:
    Options: no
  55. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  56. Additional information:
  57. Title:
    
    PAKIET 8
  58. Additional CPV code(s):
    33600000
  59. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  60. Description of the procurement:
    
    Cyclophosphamidum Endoxan inj. 0,2 g x 1 fiol. 2000.
    
    Cyclophosphamidum Endoxan inj. 1,0 g x 1 fiol. 1000.
    
    Cyclophosphamidum Endoxan tabl. 50 mg, 50 szt. 100.
  61. Award criteria:
  62. Information about options:
    Options: no
  63. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  64. Additional information:
  65. Title:
    
    PAKIET 9
  66. Additional CPV code(s):
    33600000
  67. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  68. Description of the procurement:
    
    Cytarabinum Alexan, 0,1/5ml konc. do inj., 1 fiol. 90.
    
    Cytarabinum Alexan, 1,0/20ml konc. do inj., 1 fiol. 70.
  69. Award criteria:
  70. Information about options:
    Options: no
  71. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  72. Additional information:
  73. Title:
    
    PAKIET 10
  74. Additional CPV code(s):
    33600000
  75. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  76. Description of the procurement:
    
    Dacarbazinum Detimedac, 0,1 g, inj., 10 fiol. 30.
    
    Dacarbazinum Detimedac, 0,2 g, inj., 10 fiol. 70.
  77. Award criteria:
  78. Information about options:
    Options: no
  79. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  80. Additional information:
  81. Title:
    
    PAKIET 11
  82. Additional CPV code(s):
    33600000
  83. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  84. Description of the procurement:
    
    Dexamethasoni phosphas Dexamethasone phosphate SF inj. 4mg/1ml, 5 amp. a 1 ml. 1000.
  85. Award criteria:
  86. Information about options:
    Options: no
  87. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  88. Additional information:
  89. Title:
    
    PAKIET 12
  90. Additional CPV code(s):
    33600000
  91. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  92. Description of the procurement:
    
    Docetaxel Docetaxel, 0,02g/1ml, konc.do wl.doż., 1 fiol. 200.
    
    Docetaxel Docetaxel, 0,08g/4ml, konc.do wl.doż., 1 fiol. 1700.
  93. Award criteria:
  94. Information about options:
    Options: no
  95. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  96. Additional information:
  97. Title:
    
    PAKIET 13
  98. Additional CPV code(s):
    33600000
  99. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  100. Description of the procurement:
    
    Doxorubicini hydrochloridum Doxorubicin, 200 mg/100 ml, inj., 1 fiol. 500.
  101. Award criteria:
  102. Information about options:
    Options: no
  103. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  104. Additional information:
  105. Title:
    
    PAKIET 14
  106. Additional CPV code(s):
    33600000
  107. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  108. Description of the procurement:
    
    Doxorubicini liposomamum Myocet 50 mg, prosz., 2 zest./op. 130.
  109. Award criteria:
  110. Information about options:
    Options: no
  111. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  112. Additional information:
  113. Title:
    
    PAKIET 15
  114. Additional CPV code(s):
    33600000
  115. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  116. Description of the procurement:
    
    Epirubicini hydrochloridum Epirubicin, 200 mg/100 ml, rozt.do wl.doż., 1 fiol. 350.
  117. Award criteria:
  118. Information about options:
    Options: no
  119. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  120. Additional information:
  121. Title:
    
    PAKIET 16
  122. Additional CPV code(s):
    33600000
  123. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  124. Description of the procurement:
    
    Erlotynib Tarceva, 100mg, tabl., 30 szt. 40.
    
    Erlotynib Tarceva, 150 mg, tabl., 30 szt. 80.
  125. Award criteria:
  126. Information about options:
    Options: no
  127. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  128. Additional information:
  129. Title:
    
    PAKIET 17
  130. Additional CPV code(s):
    33600000
  131. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  132. Description of the procurement:
    
    Etoposid Etoposid inj. 100mg/5ml, 1 fiol. 4500.
  133. Award criteria:
  134. Information about options:
    Options: no
  135. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  136. Additional information:
  137. Title:
    
    PAKIET 18
  138. Additional CPV code(s):
    33600000
  139. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  140. Description of the procurement:
    
    Ewerolimus Afinitor 5 mg, tabl., 30 szt. 60.
    
    Ewerolimus Afinitor 10 mg, tabl., 30 szt. 150.
  141. Award criteria:
  142. Information about options:
    Options: no
  143. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  144. Additional information:
  145. Title:
    
    PAKIET 19
  146. Additional CPV code(s):
    33600000
  147. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  148. Description of the procurement:
    
    Filgrastimum Tevagrastim, 96 mln j.m/ml, rozt.do wstrzyk., 1 amp.-strz. 0,5ml 1000.
    
    Filgrastimum Tevagrastim, 60 mln j.m/ml, rozt.do wstrzyk., 1 amp.-strz. 0,5ml 300.
  149. Award criteria:
  150. Information about options:
    Options: no
  151. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  152. Additional information:
  153. Title:
    
    PAKIET 20
  154. Additional CPV code(s):
    33600000
  155. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  156. Description of the procurement:
    
    Fludarabini phosphas Fludarabine Teva, 0,05 g/2ml, inj., 1 fiol. 80.
    
    Fludarabini phosphas Fludara, 10 mg, tabl., 20 tabl. 15.
  157. Award criteria:
  158. Information about options:
    Options: no
  159. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  160. Additional information:
  161. Title:
    
    PAKIET 21
  162. Additional CPV code(s):
    33600000
  163. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  164. Description of the procurement:
    
    Fluorouracilum Fluorouraci 5000 medac, 5 g/100ml, rozt.do wl.doż., 1 fiol.a 100ml * 3300.
    
    * Zamawiający wymaga, aby lek był kompatybilny z lekiem z pakietu 29 (dostarczyć komplet badań).
  165. Award criteria:
  166. Information about options:
    Options: no
  167. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  168. Additional information:
  169. Title:
    
    PAKIET 22
  170. Additional CPV code(s):
    33600000
  171. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  172. Description of the procurement:
    
    Gemcytabinum hydrochloridum Gemcitabinum 2,0 g/20ml, inj., 1 fiol. 1400.
  173. Award criteria:
  174. Information about options:
    Options: no
  175. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  176. Additional information:
  177. Title:
    
    PAKIET 23
  178. Additional CPV code(s):
    33600000
  179. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  180. Description of the procurement:
    
    Ifosfamidum Holoxan, 1g, inj., 1 fiol. 100.
    
    Ifosfamidum Holoxan, 2g, inj., 1 fiol. 200.
  181. Award criteria:
  182. Information about options:
    Options: no
  183. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  184. Additional information:
  185. Title:
    
    PAKIET 24
  186. Additional CPV code(s):
    33600000
  187. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  188. Description of the procurement:
    
    Interferonum alfa Roferon A, 3 mln j.m./0,5 ml, inj., 1 amp-strz. a 0,5 ml 200.
    
    Interferonum alfa Roferon A, 6 mln j.m./0,5 ml, inj., 1 amp-strz. a 0,5 ml 300.
    
    Interferonum alfa Roferon A, 9 mln j.m./0,5 ml, inj., 1 amp-strz. a 0,5 ml 500.
  189. Award criteria:
  190. Information about options:
    Options: no
  191. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  192. Additional information:
  193. Title:
    
    PAKIET 25
  194. Additional CPV code(s):
    33600000
  195. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  196. Description of the procurement:
    
    IIpilimumab Yervoy inj. 200 mg, 1 fiol. 15.
    
    Ipilimumab Yervoy inj. 50 mg, 1 fiol. 15.
  197. Award criteria:
  198. Information about options:
    Options: no
  199. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  200. Additional information:
  201. Title:
    
    PAKIET 26
  202. Additional CPV code(s):
    33600000
  203. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  204. Description of the procurement:
    
    Irinotecani hydroboromidum Irinotecan Fresenius 0,04 g/2ml, inj., 1 fiol. 2500.
    
    Irinotecani hydroboromidum Irinotecan Fresenius 0,1 g/5ml, inj., 1 fiol. 1800.
    
    Irinotecani hydroboromidum Irinotecan Fresenius 0,3 g/15ml, inj., 1 fiol. 1000.
  205. Award criteria:
  206. Information about options:
    Options: no
  207. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  208. Additional information:
  209. Title:
    
    PAKIET 27
  210. Additional CPV code(s):
    33600000
  211. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  212. Description of the procurement:
    
    Kobimetynib Cotellic, tabl. powl., 20 mg, 63 szt. 30.
  213. Award criteria:
  214. Information about options:
    Options: no
  215. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  216. Additional information:
  217. Title:
    
    PAKIET 28
  218. Additional CPV code(s):
    33600000
  219. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  220. Description of the procurement:
    
    Lapatynib Tyverb 250 mg, tabl., 140 tabl 100.
  221. Award criteria:
  222. Information about options:
    Options: no
  223. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  224. Additional information:
  225. Title:
    
    PAKIET 29
  226. Additional CPV code(s):
    33600000
  227. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  228. Description of the procurement:
    
    Levofolinic acid Levofolic roztw. do inf. 200 mg/4ml, 1 fiol. 200.
    
    Levofolinic acid Levofolic roztw. do inf. 450 mg/9ml, 1 fiol. 2800.
  229. Award criteria:
  230. Information about options:
    Options: no
  231. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  232. Additional information:
  233. Title:
    
    PAKIET 30
  234. Additional CPV code(s):
    33600000
  235. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  236. Description of the procurement:
    
    Mesnum Uromitexan, 0,4 g/4ml, inj., 15 amp. 100.
  237. Award criteria:
  238. Information about options:
    Options: no
  239. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  240. Additional information:
  241. Title:
    
    PAKIET 31
  242. Additional CPV code(s):
    33600000
  243. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  244. Description of the procurement:
    
    Mitomycinum Mitomycin C 0,01 g inj. 1 fiol. 200.
  245. Award criteria:
  246. Information about options:
    Options: no
  247. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  248. Additional information:
  249. Title:
    
    PAKIET 32
  250. Additional CPV code(s):
    33600000
  251. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  252. Description of the procurement:
    
    Ondansetroni hydrochlor. Atossa, 8 mg, 10 tab. 100.
  253. Award criteria:
  254. Information about options:
    Options: no
  255. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  256. Additional information:
  257. Title:
    
    PAKIET 33
  258. Additional CPV code(s):
    33600000
  259. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  260. Description of the procurement:
    
    Pacitaxelum Paclitaxelum 0,1g/16,7ml, inj., 1 fiol., 3500.
  261. Award criteria:
  262. Information about options:
    Options: no
  263. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  264. Additional information:
  265. Title:
    
    PAKIET 34
  266. Additional CPV code(s):
    33600000
  267. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  268. Description of the procurement:
    
    Panitumumab Vectibix, 100mg/5ml, konc.do inf., 1 fiol. 200.
    
    Panitumumab Vectibix, 400mg/20ml, konc.do inf., 1 fiol. 230.
  269. Award criteria:
  270. Information about options:
    Options: no
  271. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  272. Additional information:
  273. Title:
    
    PAKIET 35
  274. Additional CPV code(s):
    33600000
  275. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  276. Description of the procurement:
    
    Pegfilgrastimum Neulasta 6mg/0,6ml x 1 amp.strz. 1500.
  277. Award criteria:
  278. Information about options:
    Options: no
  279. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  280. Additional information:
  281. Title:
    
    PAKIET 36
  282. Additional CPV code(s):
    33600000
  283. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  284. Description of the procurement:
    
    Pemetrexed Pemetrexed, 100 mg, prosz. do przyg.roztw. do inf., 1 fiol. 500.
    
    Pemetrexed Pemetrexed, 500 mg, prosz. do przyg.roztw. do inf., 1 fiol. 300.
  285. Award criteria:
  286. Information about options:
    Options: no
  287. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  288. Additional information:
  289. Title:
    
    PAKIET 37
  290. Additional CPV code(s):
    33600000
  291. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  292. Description of the procurement:
    
    Procarbazini hydrochloridum Natulan 0,05 g, kaps., 50 kaps. 30.
  293. Award criteria:
  294. Information about options:
    Options: no
  295. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  296. Additional information:
  297. Title:
    
    PAKIET 38
  298. Additional CPV code(s):
    33600000
  299. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  300. Description of the procurement:
    
    Rituximabum Mabthera LZ, 0,01 g/1ml, konc.do wl.doż., 2 fiol.a 10ml 100.
  301. Award criteria:
  302. Information about options:
    Options: no
  303. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  304. Additional information:
  305. Title:
    
    PAKIET 39
  306. Additional CPV code(s):
    33600000
  307. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  308. Description of the procurement:
    
    Sorafenib Nexavar 200 mg, tabl., 112 szt. 200.
  309. Award criteria:
  310. Information about options:
    Options: no
  311. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  312. Additional information:
  313. Title:
    
    PAKIET 40
  314. Additional CPV code(s):
    33600000
  315. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  316. Description of the procurement:
    
    Sunitinib Sutent, 50 mg, kapsułki, 28 kaps. 300.
    
    Sunitinib Sutent, 25 mg, kapsułki, 28 kaps. 150.
    
    Sunitinib Sutent, 12,5 mg, kapsułki, 28 kaps. 120.
  317. Award criteria:
  318. Information about options:
    Options: no
  319. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  320. Additional information:
  321. Title:
    
    PAKIET 41
  322. Additional CPV code(s):
    33600000
  323. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  324. Description of the procurement:
    
    Temozolomidum Temozolomid, 5 mg, kaps.twarde, 5 szt. pakowanych oddzielnie 500.
    
    Temozolomidum Temozolomid, 20 mg, kaps.twarde, 5 szt. pakowanych oddzielnie 500.
    
    Temozolomidum Temozolomid, 100 mg, kaps.twarde, 5 szt. pakowanych oddzielnie 500.
    
    Temozolomidum Temozolomid, 140 mg, kaps.twarde, 5 szt. pakowanych oddzielnie 200.
    
    Temozolomidum Temozolomid, 180 mg, kaps.twarde, 5 szt. pakowanych oddzielnie 80.
    
    Temozolomidum Temozolomid, 250 mg, kaps.twarde, 5 szt. pakowanych oddzielnie 80.
  325. Award criteria:
  326. Information about options:
    Options: no
  327. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  328. Additional information:
  329. Title:
    
    PAKIET 42
  330. Additional CPV code(s):
    33600000
  331. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  332. Description of the procurement:
    
    Temsirolimus Torisel inj. 30mg/1,2ml, 1 fiol. 50.
  333. Award criteria:
  334. Information about options:
    Options: no
  335. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  336. Additional information:
  337. Title:
    
    PAKIET 43
  338. Additional CPV code(s):
    33600000
  339. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  340. Description of the procurement:
    
    Topotecanum Topotecan 4 mg/4ml, konc.do inj.doż, 1 fiol. 400.
    
    Topotecanum Topotecan 1 mg/1ml, konc.do inj.doż, 1 fiol. 300.
  341. Award criteria:
  342. Information about options:
    Options: no
  343. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  344. Additional information:
  345. Title:
    
    PAKIET 44
  346. Additional CPV code(s):
    33600000
  347. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  348. Description of the procurement:
    
    Topotecanum Hycamtin 1 mg, 10 kaps. twar. 40.
    
    Topotecanum Hycamtin 0,25 mg,10 kaps. twar. 20.
  349. Award criteria:
  350. Information about options:
    Options: no
  351. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  352. Additional information:
  353. Title:
    
    PAKIET 45
  354. Additional CPV code(s):
    33600000
  355. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  356. Description of the procurement:
    
    Trabectedinum Yondelis 0,25 mg x 1 fiol. 80.
    
    Trabectedinum Yondelis 1,0 mg x 1 fiol. 80.
  357. Award criteria:
  358. Information about options:
    Options: no
  359. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  360. Additional information:
  361. Title:
    
    PAKIET 46
  362. Additional CPV code(s):
    33600000
  363. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  364. Description of the procurement:
    
    Trastuzumabum Herceptin 150 mg konc.rozt.infuz., 1 fiol. 2000.
  365. Award criteria:
  366. Information about options:
    Options: no
  367. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  368. Additional information:
  369. Title:
    
    PAKIET 47
  370. Additional CPV code(s):
    33600000
  371. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  372. Description of the procurement:
    
    Trametynib Mekinist, tabl. powl. 0,5mg, 30 szt. 60.
    
    Trametynib Mekinist, tabl. powl. 2 mg, 30 szt. 60.
  373. Award criteria:
  374. Information about options:
    Options: no
  375. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  376. Additional information:
  377. Title:
    
    PAKIET 48
  378. Additional CPV code(s):
    33600000
  379. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  380. Description of the procurement:
    
    Vinblastium sulfas Vinblastin inj. 5 mg x 10 fiol. 20.
  381. Award criteria:
  382. Information about options:
    Options: no
  383. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  384. Additional information:
  385. Title:
    
    PAKIET 49
  386. Additional CPV code(s):
    33600000
  387. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  388. Description of the procurement:
    
    Vincristine sulphate Vincristin, 1 mg/1ml inj. 1 fiol. 180.
  389. Award criteria:
  390. Information about options:
    Options: no
  391. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  392. Additional information:
  393. Title:
    
    PAKIET 50
  394. Additional CPV code(s):
    33600000
  395. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  396. Description of the procurement:
    
    Vinflunine Javlor, 250mg/10ml, konc.r.do inf., 1 fiol. 20.
    
    Vinflunine Javlor, 50mg/2ml, konc.r.do inf., 1 fiol. 30.
  397. Award criteria:
  398. Information about options:
    Options: no
  399. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  400. Additional information:
  401. Title:
    
    PAKIET 51
  402. Additional CPV code(s):
    33600000
  403. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  404. Description of the procurement:
    
    Vinorelbinum Navelbine 20 mg,, 1 tabl./op. 400.
    
    Vinorelbinum Navelbine 30 mg,, 1 tabl./op. 600.
  405. Award criteria:
  406. Information about options:
    Options: no
  407. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  408. Additional information:
  409. Title:
    
    PAKIET 52
  410. Additional CPV code(s):
    33600000
  411. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  412. Description of the procurement:
    
    Vinorelbinum Neocitec 0,01 g/1ml, inj., 1 fiol. 2000.
    
    Vinorelbinum Neocitec 0,05 g/5ml, inj., 1 fiol. 1500.
  413. Award criteria:
  414. Information about options:
    Options: no
  415. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  416. Additional information:
  417. Title:
    
    PAKIET 53
  418. Additional CPV code(s):
    33600000
  419. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  420. Description of the procurement:
    
    Etanercept Enbrel, pr.+rozp., 4 x 10 mg 40.
    
    Etanercept Enbrel, pr.+rozp., 4 x 25 mg 90.
  421. Award criteria:
  422. Information about options:
    Options: no
  423. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  424. Additional information:
  425. Title:
    
    PAKIET 54
  426. Additional CPV code(s):
    33600000
  427. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  428. Description of the procurement:
    
    Dalteparin sodium Roztw. do inj. 5tyś.j.m./0,2ml x 10 amp.strz. 300.
    
    Dalteparin sodium Roztw do inj. inj. 7,5tyś.j.m./ 0,3ml x 10 amp.strz. 100.
  429. Award criteria:
  430. Information about options:
    Options: no
  431. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  432. Additional information:
  433. Title:
    
    PAKIET 55
  434. Additional CPV code(s):
    33600000
  435. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  436. Description of the procurement:
    
    Enoxaparin sodium Roztw. do inj. 20mg/0,2ml x 10 amp.strz. 30.
    
    Enoxaparin sodium Roztw. do inj. 40mg/0,4ml x 10 amp.strz. 200.
  437. Award criteria:
  438. Information about options:
    Options: no
  439. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  440. Additional information:
  441. Title:
    
    PAKIET 56
  442. Additional CPV code(s):
    33600000
  443. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  444. Description of the procurement:
    
    Nadroparin sodium Roztw. do inj. 2,85tyś.j.m/ 0,3ml x 10 amp.strz. 500.
    
    Nadroparin sodium Roztw. do inj. 5,7tyś.j.m/0,6ml x 10 amp.strz. 600.
    
    Nadroparin sodium Roztw. do inj. 47,5 tyś.j.m/5ml x 10 fiol.* 300.
    
    * w komplecie: Mini-Spike Plus V,strzykawka "tuberkulinówka" 1ml, z podziałką co 0,1ml z igłą 25 G.
  445. Award criteria:
  446. Information about options:
    Options: no
  447. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  448. Additional information:
  449. Title:
    
    PAKIET 57
  450. Additional CPV code(s):
    33600000
  451. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  452. Description of the procurement:
    
    Acidum folicum Acidum folicum, 15 mg, tabl., 30 tabl. 100.
    
    Acidum folicum Acidum folicum, 5 mg, tabl., 30 tabl. 50.
  453. Award criteria:
  454. Information about options:
    Options: no
  455. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  456. Additional information:
  457. Title:
    
    PAKIET 58
  458. Additional CPV code(s):
    33600000
  459. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  460. Description of the procurement:
    
    Allantoine Alantan 2 % maść, 30 g 150.
    
    Allantoinum,Acid.boric.Zinci oxydum Alantan 0.5 %, puder lecz., 100 g 50.
  461. Award criteria:
  462. Information about options:
    Options: no
  463. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  464. Additional information:
  465. Title:
    
    PAKIET 59
  466. Additional CPV code(s):
    33600000
  467. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  468. Description of the procurement:
    
    Alprazolamum Alpragen 0,25 mg, tabl., 30 tabl. 50.
    
    Alprazolamum Alpragen 0,5 mg, tabl., 30 tabl. 50.
  469. Award criteria:
  470. Information about options:
    Options: no
  471. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  472. Additional information:
  473. Title:
    
    PAKIET 60
  474. Additional CPV code(s):
    33600000
  475. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  476. Description of the procurement:
    
    Aluminium acetotatrate Altacet, 1 g, tabl., 6 tabl. 150.
    
    Aluminium acetotatrate Altacet, 1 % (10mg/g), żel, 75 g 500.
  477. Award criteria:
  478. Information about options:
    Options: no
  479. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  480. Additional information:
  481. Title:
    
    PAKIET 61
  482. Additional CPV code(s):
    33600000
  483. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  484. Description of the procurement:
    
    Ambroxoli hydrochloridum Aflegan, 0,015 g/2ml, inj., 10 amp. 200.
    
    Ambroxoli hydrochloridum Ambroksol, 30mg/5ml, syrop, 150 ml 5.
    
    Ambroxoli hydrochloridum Deflegmin retard, 0,075 g, kaps., 10 kaps. 70.
  485. Award criteria:
  486. Information about options:
    Options: no
  487. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  488. Additional information:
  489. Title:
    
    PAKIET 62
  490. Additional CPV code(s):
    33600000
  491. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  492. Description of the procurement:
    
    Amiloridi hydroch.+ Hydrochlorothiazidu Tialorid mite, tabl., 50 tabl. 20.
    
    Amiloridi hydroch.+ Hydrochlorothiazidu Tialorid, tabl., 50 tabl. 20.
  493. Award criteria:
  494. Information about options:
    Options: no
  495. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  496. Additional information:
  497. Title:
    
    PAKIET 63
  498. Additional CPV code(s):
    33600000
  499. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  500. Description of the procurement:
    
    Amiodaroni hydrochloridum Cordarone, 0,15 g/3ml, inj., 6 amp. 200.
    
    Amiodaroni hydrochloridum Cordarone, 0,2 g, tabl.powl., 30 tabl. 100.
  501. Award criteria:
  502. Information about options:
    Options: no
  503. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  504. Additional information:
  505. Title:
    
    PAKIET 64
  506. Additional CPV code(s):
    33600000
  507. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  508. Description of the procurement:
    
    Amitriptylini hydrochloridum Amitriptylinum, 0,01 g, draż., 60 draż. 20.
    
    Amitriptylini hydrochloridum Amitriptylinum, 0,025 g, draż., 60 draż. 30.
  509. Award criteria:
  510. Information about options:
    Options: no
  511. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  512. Additional information:
  513. Title:
    
    PAKIET 65
  514. Additional CPV code(s):
    33600000
  515. Place of performance:
    Main site or place of performance:
    APTEKA SZPITALNA.
  516. Description of the procurement:
    
    Amoxicillinum Ospamox, 0,25 g/5ml, gran.do p.zaw., 24 g/60 ml 30.
    
    Amoxicillinum Ospamox, 1 g, tabl.powl. 16 szt. 400.
    
    Amoxicillinum Ospamox 0,5 g, tabl.powl. 16 szt. 50.
  517. Award criteria:
  518. Information about options:
    Options: no
  519. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  520. Copyright © 2016-2024, TenderInfo.Org
    All rights reserved.
    E-mail: [email protected]
    
    Terms and conditions Site calendar

Pharmaceutical products (№6443407)

Link to original

Publication date

Description